Oppenheimer & Co. Inc. lessened its stake in Medical Properties Trust, Inc. (NYSE:MPW – Free Report) by 14.0% in the third quarter, HoldingsChannel reports. The firm owned 19,500 shares of the real estate investment trust’s stock after selling 3,176 shares during the period. Oppenheimer & Co. Inc.’s holdings in Medical Properties Trust were worth $114,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Future Financial Wealth Managment LLC bought a new stake in Medical Properties Trust in the third quarter valued at about $29,000. Versant Capital Management Inc increased its holdings in Medical Properties Trust by 435.0% in the second quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 6,482 shares during the last quarter. Iron Horse Wealth Management LLC increased its holdings in Medical Properties Trust by 166.7% in the second quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock valued at $34,000 after purchasing an additional 5,000 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Medical Properties Trust by 107.3% in the third quarter. GAMMA Investing LLC now owns 6,077 shares of the real estate investment trust’s stock worth $36,000 after acquiring an additional 3,145 shares in the last quarter. Finally, Gateway Investment Advisers LLC bought a new stake in shares of Medical Properties Trust in the second quarter worth about $45,000. Institutional investors own 71.79% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have issued reports on MPW shares. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price target for the company in a report on Friday, September 13th. Wolfe Research upgraded Medical Properties Trust to a “hold” rating in a report on Monday, September 23rd. Finally, Truist Financial increased their price target on Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a report on Friday, September 13th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $5.50.
Medical Properties Trust Stock Performance
Shares of NYSE MPW opened at $4.31 on Friday. The stock has a 50 day moving average price of $5.03 and a 200 day moving average price of $4.90. Medical Properties Trust, Inc. has a 52 week low of $2.92 and a 52 week high of $6.55. The company has a debt-to-equity ratio of 1.69, a quick ratio of 2.38 and a current ratio of 2.38. The stock has a market capitalization of $2.59 billion, a PE ratio of -1.02, a price-to-earnings-growth ratio of 0.65 and a beta of 1.32.
Medical Properties Trust Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, December 12th will be given a dividend of $0.08 per share. The ex-dividend date of this dividend is Thursday, December 12th. This represents a $0.32 annualized dividend and a yield of 7.42%. Medical Properties Trust’s dividend payout ratio (DPR) is presently -7.58%.
Insider Activity at Medical Properties Trust
In other news, Director C Reynolds Thompson III sold 20,530 shares of the firm’s stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the completion of the sale, the director now directly owns 54,637 shares of the company’s stock, valued at $239,310.06. This trade represents a 27.31 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Michael G. Stewart sold 32,780 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $5.46, for a total value of $178,978.80. Following the completion of the sale, the director now directly owns 221,245 shares of the company’s stock, valued at approximately $1,207,997.70. The trade was a 12.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.53% of the company’s stock.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.
See Also
- Five stocks we like better than Medical Properties Trust
- 3 Stocks to Consider Buying in October
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 11/18 – 11/22
- What is the Dow Jones Industrial Average (DJIA)?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding MPW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medical Properties Trust, Inc. (NYSE:MPW – Free Report).
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.